USC Trojans Sign Revolutionary Partnership With CBD/Cannabis Company Cookies

  • 📰 SInow
  • ⏱ Reading Time:
  • 53 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 63%

ประเทศไทย ข่าว ข่าว

ประเทศไทย ข่าวล่าสุด,ประเทศไทย หัวข้อข่าว

The USC Trojans have announced a revolutionary partnership with a famous CBD/Cannabis company based out of Los Angeles. USC is adjusting successfully in the Name, Image, Likeness era of college football.

has announced a new partnership with Cookies, a popular CBD/cannabis and wellness company. Cookies will work with with both Trojans men's and women's basketball and football team. The Trojans are the first school to sign with the company, or any CBD company, making them trailblazers for this new endeavor.

Cookies branding will be seen in social media accounts for the teams as well as exclusive promotional events and tailgate experiences atSep 7, 2024; Los Angeles, California, USA; USC Trojans wide receiver Zachariah Branch runs the ball against Utah State Aggies linebacker Jon Ross Maye during the second quarter at United Airlines Field at Los Angeles Memorial Coliseum.

Over the summer, the NCAA voted to remove cannabinoids from their banned susbstances list. With the Trojans making the first step into the world of cannabinoid partnerships, it will be interesting to see what happens from here. The Trojans with the highest NIL valuations are quarterback Miller Moss , women's basketball player Juju Watkins , wide receiver Zachariah Branch , safety Kamari Ramsey and defensive tackle Bear Alexander .

Sep 1, 2024; Paradise, Nevada, USA; Southern California Trojans quarterback Miller Moss reacts after the game against the LSU Tigers at Allegiant Stadium. Mandatory Credit: Kirby Lee-Imagn Images / Kirby Lee-Imagn Images

เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:

 /  🏆 273. in TH
 

ขอบคุณสำหรับความคิดเห็นของคุณ ความคิดเห็นของคุณจะถูกเผยแพร่หลังจากได้รับการตรวจสอบแล้ว

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว